CULTURE MEDIUM FOR EUKARYOTIC CELLS
    2.
    发明申请
    CULTURE MEDIUM FOR EUKARYOTIC CELLS 审中-公开
    文化细胞培养基

    公开(公告)号:WO2009020389A1

    公开(公告)日:2009-02-12

    申请号:PCT/NL2008/050534

    申请日:2008-08-04

    IPC分类号: C12N5/02 C12P21/00

    摘要: A proteolysate of a seed material derived from a plant species of the Asteraceae family, such as sunflower, has improved properties as a constituent of a culture medium for culturing eukaryotic, in particular animal cells. The seed material is defatted and is hydrolysed to a degree of 10 - 50% and subsequently separated from insolubles. The cells are particularly cultured for producing desir ed protein products.

    摘要翻译: 衍生自菊科的植物物种如向日葵的种子材料的蛋白水解作为培养真核生物,特别是动物细胞的培养基的组分具有改进的性质。 种子材料脱脂并水解至10-50%的程度,随后与不溶物分离。 细胞被特别培养用于生产需要的蛋白质产物。

    USE OF A PROTEIN HYDROLYSATE FOR ENHANCING ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1
    3.
    发明申请
    USE OF A PROTEIN HYDROLYSATE FOR ENHANCING ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1 审中-公开
    蛋白水解酶用于增强葡萄球菌肽-1活性的应用

    公开(公告)号:WO2007064208A1

    公开(公告)日:2007-06-07

    申请号:PCT/NL2006/050301

    申请日:2006-11-30

    CPC分类号: A61K35/20

    摘要: A protein hydrolysate having a degree of hydrolysis between 1 and 40% and containing between 1 and 70 wt.% of peptides having a molecular weight of less than 500 Da and less than 55 wt.% of peptides or proteins having a molecular weight of more than 5000 Da, on the basis of the total proteinaceous material of the composition, is effective in stimulating secretion of glucagon- like peptide- 1 (GLP-I). In addition, the hydrolysate may have DPP-IV inhibiting activity. The hydrolysate is suitable for the manufacture of a medicament, or food product for prophylaxis and/or treatment of a GLP-I mediated condition, in particular obesity, type 2 diabetes mellitus and an immunological disorder.

    摘要翻译: 具有1至40%之间水解度并含有1至70重量%的分子量小于500Da且小于55重量%的分子量更大的肽或蛋白质的肽的蛋白质水解产物 基于组合物的总蛋白质物质的5000Da有效刺激胰高血糖素样肽-1(GLP-1)的分泌。 此外,水解产物可能具有DPP-IV抑制活性。 该水解产物适用于制备用于预防和/或治疗GLP-1介导的病症,特别是肥胖症,2型糖尿病和免疫学障碍的药物或食品。

    DERMATOLOGIC USE OF MILK PROTEINS
    4.
    发明申请
    DERMATOLOGIC USE OF MILK PROTEINS 审中-公开
    乳清蛋白的微生物学应用

    公开(公告)号:WO2006098625A1

    公开(公告)日:2006-09-21

    申请号:PCT/NL2006/050055

    申请日:2006-03-14

    IPC分类号: A61K35/20 A61K38/40 A61P17/10

    摘要: The invention provides a method for the treatment of acne comprising orally administering to a person suffering from acne an effective amount of a whey protein fraction containing lactoferrin, and preferably containing further specific whey proteins. The lactoferrin is preferably native bovine lactoferrin and the whey protein fraction is administered at a level of between 10 mg and 2 g lactoferrin per patient per day.

    摘要翻译: 本发明提供了一种治疗痤疮的方法,包括口服给予痤疮患者有效量的含有乳铁蛋白的乳清蛋白质级分,并且优选含有其它特异性乳清蛋白。 乳铁蛋白优选为天然牛乳铁蛋白,并且乳清蛋白级分每天患者以10mg至2g乳铁蛋白的水平施用。

    HEAT-STABLE, AQUEOUS LACTOFERRIN COMPOSITION AND ITS PREPARATION AND USE
    6.
    发明申请
    HEAT-STABLE, AQUEOUS LACTOFERRIN COMPOSITION AND ITS PREPARATION AND USE 审中-公开
    热稳定,水性柠檬素组合物及其制备和使用

    公开(公告)号:WO2009154447A1

    公开(公告)日:2009-12-23

    申请号:PCT/NL2009/050342

    申请日:2009-06-15

    IPC分类号: A61K38/40 A61K47/26 A23L1/305

    摘要: The invention pertains to an aqueous composition containing lactoferrin, 35 –70 wt% carbohydrate and/or polyol stabilizers, based on the total weight of the aqueous composition, said composition exhibiting a pH higher than 2, lower than 5. At these 5 conditions, the aqueous composition and lactoferrin contained therein may be subjected to a heat treatment without significantly affecting the physiological activity of the lactoferrin. The invention thus particularly pertains to the above aqueous composition, being heat-treated, thus containing heat-stabilized lactoferrin.

    摘要翻译: 本发明涉及基于水性组合物的总重量含有乳铁蛋白,35-70重量%碳水化合物和/或多元醇稳定剂的含水组合物,所述组合物的pH高于2,低于5.在这5个条件下, 可以对其中含有的水性组合物和乳铁蛋白进行热处理,而不会显着影响乳铁蛋白的生理活性。 因此,本发明特别涉及上述水性组合物,经过热处理,因此含有热稳定的乳铁蛋白。